Article Details

Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co ... - PR Newswire

Retrieved on: 2022-07-25 10:58:50

Tags for this article:

Click the tags to see associated articles and topics

Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co ... - PR Newswire. View article details on HISWAI: https://www.prnewswire.com/news-releases/anti-pd-1-monoclonal-antibody-puyouheng-hx-008-pucotenlimab-injection-co-developed-by-lepu-biopharma-and-hanx-biopharmaceuticals-was-approved-for-marketing-in-china-by-nmpa-301592305.html

Excerpt

PRNewswire/ -- Anti-PD-1 monoclonal antibody – PuyouhengTM (HX-008, pucotenlimab injection), was conditionally approved by the National Medical ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up